Neuroprotection of green tea catechins on surgical menopause-induced overactive bladder in a rat model

Menopause

Volumn 19, Issue 3, 2012, Pages 346-354

  Juan, Yung Shun ^a,b   Chuang, Shu Mien ^a   Long, Cheng Yu ^a,c   Chen, Chung Hwan ^b   Levin, Robert M ^d   Liu, Keh Min ^a   Huang, Chun Hsiung ^b  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

^d ALBANY COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

Author keywords

Catechin; Muscarinic receptor; Ovariectomy; Overactive bladder

Indexed keywords

EPIGALLOCATECHIN GALLATE; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MEGADOSE; FEMALE; LOW DRUG DOSE; NEUROFILAMENT; NEUROPROTECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; OVARIECTOMY; OVERACTIVE BLADDER; PROTEIN EXPRESSION; RAT; TEA;

ANIMALS; CATECHIN; DISEASE MODELS, ANIMAL; FEMALE; MENOPAUSE; NEUROPROTECTIVE AGENTS; OVARIECTOMY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, MUSCARINIC M2; RECEPTOR, MUSCARINIC M3; TEA; URINARY BLADDER, OVERACTIVE;

EID: 84857647535     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/gme.0b013e31822d652d     Document Type: Article

References (38)

1. Stewart WF, Van Rooyen JB, Cundiff GW, et al. Prevalence and burden of overactive bladder in the United States. World J Urol 2003; 20:327-336. (Pubitemid 44175300)
2. Chen GD, Hu SW, Chen YC, Lin TL, Lin LY. Prevalence and correlations of anal incontinence and constipation in Taiwanese women. Neurourol Urodyn 2003;22:664-669.
3. Chen JJ, Ye ZQ, Koo MW. Growth inhibition and cell cycle arrest effects of epigallocatechin gallate in the NBT-II bladder tumour cell line. BJU Int 2004;93:1082-1086. (Pubitemid 38758638)
4. Liang W, Afshar K, Stothers L, Laher I. The influence of ovariectomy and estrogen replacement on voiding patterns and detrusor muscarinic receptor affinity in the rat. Life Sci 2002;71:351-362. (Pubitemid 34597196)
5. Lin AD, Mannikarottu A, Kogan BA, et al. Estrogen induces angiogenesis of the female rabbit bladder. J Endocrinol 2006;190:241-246. (Pubitemid 44288362)
6. Lin AD, Levin R, Kogan B, et al. Estrogen induced functional hypertrophy and increased force generation of the female rabbit bladder. Neurourol Urodyn 2006;25:473-479.
7. Ekstrom J, Iosif CS, Malmberg L. Effects of long-term treatment with estrogen and progesterone on in vitro muscle responses of the female rabbit urinary bladder and urethra to autonomic drugs and nerve stimulation. J Urol 1993;150:1284-1288. (Pubitemid 23272526)
8. Long CY, Liu CM, Hsu SC, Chen YH, Wu CH, Tsai EM. A randomized comparative study of the effects of oral and topical estrogen therapy on the lower urinary tract of hysterectomized postmenopausal women. Fertil Steril 2006;85:155-160.
9. Long CY, Liu CM, Hsu SC, Wu CH, Wang CL, Tsai EM. A randomized comparative study of the effects of oral and topical estrogen therapy on the vaginal vascularization and sexual function in hysterectomized postmenopausal women. Menopause 2006;13:737-743.
10. Weiderpass E, Baron JA, Adami HO, et al. Low-potency oestrogen and risk of endometrial cancer: a case-control study. Lancet 1999;353: 1824-1828. (Pubitemid 29251013)
11. Ettinger B. Personal perspective on low-dosage estrogen therapy for postmenopausal women. Menopause. 1999;6:273-276. (Pubitemid 29418973)
12. Pan MH, Lin-Shiau SY, Ho CT, Lin JH, Lin JK. Suppression of lipopolysaccharide-induced nuclear factor-JB activity by theaflavin-3, 3¶-digallate from black tea and other polyphenols through downregulation of IJB kinase activity in macrophages. Biochem Pharmacol 2000;59:357-367.
13. Higdon JV, Frei B. Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Crit Rev Food Sci Nutr 2003;43: 89-143. (Pubitemid 38552312)
14. Philips BJ, Coyle CH, Morrisroe SN, Chancellor MB, Yoshimura N. Induction of apoptosis in human bladder cancer cells by green tea catechins. Biomed Res 2009;30:207-215.
15. Kurahashi N, Inoue M, Iwasaki M, Sasazuki S, Tsugane S. Coffee, green tea, and caffeine consumption and subsequent risk of bladder cancer in relation to smoking status: a prospective study in Japan. Cancer Sci 2009;100:284-291.
16. Qin J, Xie LP, Zheng XY, et al. A component of green tea, (j)-epigallocatechin-3-gallate, promotes apoptosis in T24 human bladder cancer cells via modulation of the PI3K/Akt pathway and Bcl-2 family proteins. Biochem Biophys Res Commun 2007;354:852-857. (Pubitemid 46216211)
17. Juan YS, Levin RM, Chuang SM, et al. The beneficial effect of coenzyme Q10 and lipoic acid on obstructive bladder dysfunction in the rabbit. J Urol 2008;180:2234-2240.
18. Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Subcommittee of the International Continence Society. Neurourol Urodyn 2002;21:167-178. (Pubitemid 34195211)
19. Juan YS, Mannikarottu A, Kogan BA, et al. The effect of low-dose estrogen therapy on ovariectomized female rabbit bladder. Urology 2008;71:1209-1213.
20. Yoshida J, Aikawa K, Yoshimura Y, Shishido K, Yanagida T, Yamaguchi O. The effects of ovariectomy and estrogen replacement on acetylcholine release from nerve fibres and passive stretch-induced acetylcholine release in female rat bladder. Neurourol Urodyn 2007;26: 1050-1055. (Pubitemid 350085909)
21. Wang P, Luthin GR, Ruggieri MR. Muscarinic acetylcholine receptor subtypes mediating urinary bladder contractility and coupling to GTP binding proteins. J Pharmacol Exp Ther 1995;273:959-966.
22. Giglio D, Tobin G. Muscarinic receptor subtypes in the lower urinary tract. Pharmacology 2009;83:259-269.
23. Tong YC, Cheng JT. Alterations of M2,3-muscarinic receptor protein and mRNA expression in the bladder of the fructose fed obese rat. J Urol 2007;178:1537-1542.
24. Braverman AS, Ruggieri MR Sr. Muscarinic receptor transcript and protein density in hypertrophied and atrophied rat urinary bladder. Neurourol Urodyn 2006;25:55-61. (Pubitemid 43050209)
25. Braverman AS, Tallarida RJ, Ruggieri MR Sr. Interaction between muscarinic receptor subtype signal transduction pathways mediating bladder contraction. Am J Physiol Regul Integr Comp Physiol 2002;283: R663-R668. (Pubitemid 34951620)
26. Long CY, Hsu CS, Shao PL, Liu CM, Su JH, Tsai EM. Effect of ovariectomy on the gene expression of detrusor muscarinic receptors in female rats. Fertil Steril 2009;92:1147-1149.
27. Grunblatt E, Mandel S, Jacob-Hirsch J, et al. Gene expression profiling of parkinsonian substantia nigra pars compacta; alterations in ubiquitinproteasome, heat shock protein, iron and oxidative stress regulated proteins, cell adhesion/cellular matrix and vesicle trafficking genes. J Neural Transm 2004;111:1543-1573. (Pubitemid 40068786)
28. Gerlach M, Double KL, Ben-Shachar D, Zecca L, Youdim MB, Riederer P. Neuromelanin and its interaction with iron as a potential risk factor for dopaminergic neurodegeneration underlying Parkinson's disease. Neurotox Res 2003;5:35-44.
29. Guo Q, Zhao B, Li M, Shen S, Xin W. Studies on protective mechanisms of four components of green tea polyphenols against lipid peroxidation in synaptosomes. Biochim Biophys Acta 1996;1304:210-222. (Pubitemid 26426992)
30. Levites Y, Youdim MB, Maor G, Mandel S. Attenuation of 6-hydroxydopamine (6-OHDA)Yinduced nuclear factor-JB (NF-JB) activation and cell death by tea extracts in neuronal cultures. Biochem Pharmacol 2002;63:21-29. (Pubitemid 34075289)
31. Schroeder EK, Kelsey NA, Doyle J, et al. Green tea epigallocatechin 3-gallate accumulates in mitochondria and displays a selective antiapoptotic effect against inducers of mitochondrial oxidative stress in neurons. Antioxid Redox Signal 2009;11:469-480.
32. Levites Y, Weinreb O, Maor G, Youdim MB, Mandel S. Green tea polyphenol (j)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3, 6-tetrahydropyridineYinduced dopaminergic neurodegeneration. J Neurochem 2001;78:1073-1082. (Pubitemid 32823156)
33. Weinreb O, Mandel S, Youdim MB. Gene and protein expression profiles of anti-and pro-apoptotic actions of dopamine, R-apomorphine, green tea polyphenol (j)-epigallocatechine-3-gallate, and melatonin. Ann N Y Acad Sci 2003;993:351-361; discussion 87-93. (Pubitemid 36808465)
34. Mandel S, Grunblatt E, Youdim M. cDNA microarray to study gene expression of dopaminergic neurodegeneration and neuroprotection in MPTP and 6-hydroxydopamine models: implications for idiopathic Parkinson's disease. J Neural Transm Suppl 2000;117-124. (Pubitemid 32037188)
35. Mandel S, Weinreb O, Youdim MB. Using cDNA microarray to assess Parkinson's disease models and the effects of neuroprotective drugs. Trends Pharmacol Sci 2003;24:184-191. (Pubitemid 36428820)
36. Lambert JD, Yang CS. Cancer chemopreventive activity and bioavailability of tea and tea polyphenols. Mutat Res 2003;523-524:201-208. (Pubitemid 36293247)
37. Kim S, Lee MJ, Hong J, et al. Plasma and tissue levels of tea catechins in rats and mice during chronic consumption of green tea polyphenols. Nutr Cancer 2000;37:41-48. (Pubitemid 30650665)
38. Chow HH, Cai Y, Hakim IA, et al. Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and Polyphenon E in healthy individuals. Clin Cancer Res 2003; 9:3312-3319. (Pubitemid 37082725)